Recombinant vaccine against West Nile Virus
AssigneeMerial Limited
InventorsSheena May Loosmore, Jean-Christophe Francis Audonnet, Jules Maarten Minke
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerial Limited
InventorsSheena May Loosmore, Jean-Christophe Francis Audonnet, Jules Maarten Minke
Estimating the term…
An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The vector contains heterologous nucleic acid molecule(s), expresses in vivo in the animal WNV antigen, immunogen or epitope thereof, e.g., WNV E; WNV prM and E; WNV M and E; WNV prM, WNV M and E, WNV polyprotein prM-E, WNV polyprotein M-E, or WNV polyprotein prM-M-E. The composition can contain an adjuvant, such as carbomer. Methods for making and using such a composition, including prime-boost regimes and including as to differential diagnosis, are also contemplated.
A composition comprising a recombinant poxvirus or DNA plasmid comprising a polynucleotide, wherein the polynucleotide encodes and expresses WVN (West Nile Virus) prM-M-E having the amino acid sequence as set forth in SEQ ID NO:59.
A composition comprising a recombinant poxvirus or DNA plasmid comprising a polynucleotide, wherein the polynucleotide encodes and expresses WVN E having the amino acid sequence corresponding to amino acid positions 186-686 of SEQ ID NO:59.
A composition comprising a recombinant poxvirus or DNA plasmid comprising a polynucleotide, wherein the polynucleotide encodes and expresses WVN M-E having the amino acid sequence corresponding to amino acid positions 111-686 of SEQ ID NO:59.
A composition comprising a recombinant poxvirus or DNA plasmid comprising a polynucleotide, wherein the polynucleotide encodes and expresses WVN prM-M-E having the amino acid sequence corresponding to amino acid positions 19-686 of SEQ ID NO:59.
A composition comprising a recombinant poxvirus or DNA plasmid comprising a polynucleotide, wherein the polynucleotide encodes and expresses WVN prM-E having the amino acid sequence corresponding to amino acid positions 19-110 and 186-686 of SEQ ID NO:59.
Dependencies are inferred from the claim text.